Found 217 matching trials
Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer PHASE2 RATIONALE: Gene-modified lymphocytes may stimulate the immune system in dif...
Show More Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Learn More & Join Trial
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation EARLY_PHASE1 The purpose of this study is to determine the efficacy of aprepitant in pre...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Genetically Modified Cells (KIND T Cells) for the Treatment of HLA-A*0201-Positive Patients With H3.3K27M-Mutated Glioma PHASE1 This phase I, first-in-human trial tests the safety, side effects, and best...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma PHASE1 The primary objectives of this study are:
Phase 1: To evaluate the safety ...
Show More Location
Stanford Cancer Institute
Learn More & Join Trial
Autologous Followed by Non-myeloablative Allogeneic Transplantation for Non-Hodgkin's Lymphoma PHASE2 The purpose of this trial is to develop an alternative treatment for patien...
Show More Location
Stanford University School of Medicine
Learn More & Join Trial
A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies PHASE1 This is a global, open-label, multi-arm, parallel multi-cohort, multi-cente...
Show More Location
Local Institution - 011
Learn More & Join Trial
Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas PHASE2 This study is being conducted to evaluate the safety and efficacy of the co...
Show More Location
Miami Cancer Institute at Baptist Health, Inc.
Learn More & Join Trial
Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer PHASE1 The purpose of this study is to assess the safety and tolerability and dete...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center, City of Hope Medical Center
Learn More & Join Trial
Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients PHASE1 This is a multi-center, phase I/II study to determine the efficacy and safe...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immunomodulating Radiotherapy in Metastatic RCC PHASE2 Single center, open-label Proof of Principle phase II trial to assess objec...
Show More Location
UO Immunoterapia e Laboratorio TCS, IRCCS IRST
Learn More & Join Trial